Literature DB >> 7681114

Distinct hypomyelinated phenotypes in MBP-SV40 large T transgenic mice.

N A Jensen1, G M Smith, H D Shine, J S Garvey, L Hood.   

Abstract

To study the effect of SV40 large T-antigen expression in myelin-forming cells of both the central and peripheral nervous system, a series of transgenic mice were generated expressing the SV40 large T-antigen under control of the myelin basic protein (MBP) promoter. Two neurologic phenotypes, designated A and B, appeared among individual transgenic founders and their progeny. The A mice developed a severe action tremor at about 10 days of age that progressed into periods of convulsions and early death by three to four weeks of age. In contrast, the B mice exhibited a progressive hindlimb ataxia and had a more normal lifespan. The A mice displayed hypomyelinating lesions in the central nervous system (CNS), whereas the B mice had lesions in either the peripheral nervous system (PNS) alone or in both the PNS and CNS. Immunohistochemical staining of spinal cord sections of a type A mouse showed a substantial depletion in MBP. Moreover, T-antigen-positive cells appeared predominantly in white matter tracts as randomly distributed single cells. Double labeling immunocytochemistry demonstrated that some of these T-antigen-positive cells were positive for oligodendrocyte differentiation markers MBP and O4. Thus, T-antigen expression appeared to coincide with a terminal stage of oligodendrocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681114     DOI: 10.1002/jnr.490340302

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  3 in total

1.  Neurological disturbances, premature lethality, and central myelination deficiency in transgenic mice overexpressing the homeo domain transcription factor Oct-6.

Authors:  N A Jensen; K M Pedersen; J E Celis; M J West
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

2.  Transgenic mouse model for neurocristopathy: Schwannomas and facial bone tumors.

Authors:  N A Jensen; M L Rodriguez; J S Garvey; C A Miller; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

3.  Human COL2A1-directed SV40 T antigen expression in transgenic and chimeric mice results in abnormal skeletal development.

Authors:  K S Cheah; A Levy; P A Trainor; A W Wai; T Kuffner; C L So; K K Leung; R H Lovell-Badge; P P Tam
Journal:  J Cell Biol       Date:  1995-01       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.